Anti-Viral Metabolites from Medicinal Plants

Dr. Dilipkumar Pal (M. Pharm, Ph.D, F.I.C., Chartered Chemist, Post Doct. in Australia) is now working in the post of Associate Professor, Department of Pharmaceutical Sciences, Guru Ghasidash Vishwavidyalaya (A Central University), Bilaspur, C.G., 495 009, India. He received his master and PhD degree from Jadavpur University, Kolkata and performed post doctoral research as an “Endeavour research fellow” at the University of Sydney, Australia. His areas of research interest include “Phytochemical and pharmacological evaluation of indigenous plants” and ‘Natural Biopolymers’. He has published 177 full research papers in peer-reviewed national and international scientific journals and contributed 117 abstracts in different national and international conferences, mostly related to his specialisation. He has written 2 books and 65 book chapters and edited 08 books published by reputed international publishers. His research publications have acquired a highly remarkable cited recordin Scopus and Google Scholar (H-Index: 44; i-10-index 103, citation 6312 till date). During Dr. Pal's 21 year research-oriented teaching profession he has received 13 prestigious national and international professional awards. He has guided 8 Ph. D and 40 master students for their dissertation thesis. He is the reviewer and Editorial Board member of 27 and 29 scientific journals, respectively. Dr Pal has been working as the Editor-in-Chief of one research journal also. He is the member and life member of many professional organizations. Recently, Dr Pal has been included in World’s top 2 % Indian Scientist (Pharmacy and Pharmacology) (as released by Stanford University, USA).

• Chapter 1 Introduction of medicinal plants as source of anti-viral metabolite(s), effects on health and general adverse effects.- Chapter 2:General plants showing anti-viral activity giving emphasis on CDRI’s biological screening programme.- Chapter 3: Classification of medicinal plants having anti-viral activity as per (i) family and (ii) types of viral infections.- Chapter 4: Ethnopharmacology, Chemistry, Clinical and preclinical studies focusing on use of different medicinal plants against Herpes simplex virus (HSV) Type 1 infections.- Chapter 5: Ethnopharmacology, Chemistry, Clinical and preclinical studies focusing on use of different medicinal plants against Herpes simplex virus (HSV) Type 2 infections.- Chapter 6: Role of various medicinal plants against in HIV infection in human with possible mechanism of action and functions of secondary metabolites.- Chapter 7: Ethnopharmacology, chemistry, clinical and preclinical studies focusing on use of different medicinal plants against Hepatitis B infections.- Chapter 8: Antiviral effects of different medicinal plants against Hepatitis C (HCV) infection: Role of phytochemicals.- Chapter 9: Medicinal plants in controlling Pox virus affections:Ethnopharmacology, chemistry, clinical, preclinical studies and future perspectives.- Chapter 10: Role of medicinal plants in prevention and treatment of Respiratory viral infections.- Chapter 11: Assessment of effectiveness of herbal drugs in prevention and treatment against Gastrointestinal viral diseases.- Chapter 12: Antiviral potential of medicinal plants in treatment of diseases caused by Influenza virus A: Role of secondary metabolites, clinical and preclinical studies and future perspectives.- Chapter 13: Role of medicinal plants in treatment of diseases caused by Influenza virus B and Parainfluenza virus type 3.- Chapter 14: Ethnopharmacology, chemistry, clinical and preclinical studies focusing on the uses of herbal drugs against Polio Infections.- Chapter 15: Ethnopharmacology, chemistry, clinical and preclinical studies focusing on use of medicinal plants against SARS-CoV/Corona virus infections.- Chapter 16: Medicinal plants in controlling and treatment of diseases caused by Viral Haemorrhagic Septicaemia Virus (VHSV).- Chapter 17:Ethnopharmacology, chemistry, Clinical and preclinical studies focusing on use of different medicinal plants against vesicular stomatitis virus (VSV) infections.- Chapter 18: Ethnopharmacology, chemistry, clinical and preclinical studies focusing on use of various medicinal plants against Human Adenovirus Type 1 infections.- Chapter 19: Medicinal plants used by traditional medical practitioner in controlling and treatment of Cutaneous viral diseases: Ethnopharmacology, chemistry, Clinical and preclinical studies.- Chapter 20: Herbal drugs and medicinal plants in controlling and treatment for the diseases caused by Dengue virus (DEN-1 & 2): Ethnopharmacology, chemistry, clinical and preclinical studies.- Chapter 21: Ethnopharmacology, chemistry, Clinical and preclinical studies focusing on use of natural medicinal plants against Neurological viral diseases.- Chapter 22: Ethnopharmacology, chemistry, clinical and preclinical studies focusing on traditional crude drugs against Encephalitis infection.- Chapter 23: Ethnopharmacology, chemistry, Clinical and preclinical studies focusing on use natural plants in the treatment of Renal syndrome caused by viruses.- Chapter 24: Natural products in controlling and treatment of cancers and genital warts caused by different viruses.- Chapter 25: Role of traditional plants in controlling and treatment of fever, joint pain and pogosta diseases caused by viruses.- Chapter 26: Natural medicinal plants used in in controlling and treatment of diseases caused by Coxsackie and Coxsackie virus B3 with possible mechanism of action and role of phytochemicals.-Chapter 27: Phytochemical, clinical and preclinical studies focusing on use Indigenous plants against Cytomegalovirus, Cytomegalovirus B1 and Epstein-Barr virus infection: Prevalence and impact on patients with haematological diseases.- Chapter 28: Flavonoids: promising natural compounds against viral infections: Ethnopharmacology, chemistry, mechanism of action, clinical, preclinical studies and future perspectives.- Chapter 29: Coumarins: emerging antiviral compounds from natural origin: Ethnopharmacology, chemistry, mechanism of action, clinical, preclinical studies and future perspectives.- Chapter 30: Antiviral potential of Curcumins: Ethnopharmacology, chemistry, clinical studies focusing on mechanism of action and future perspectives.